Three plants are part of the company’s pharmaceutical division, while the fourth plant is part of the medical device division. Johnson & Johnson will invest up to $225 million to expand the facilities, which will make way for more than 300 new jobs.
More Articles on Orthopedic Devices:
Arthritis Foundation to Honor Dr. James Marvel
Zimmer Celebrates 15 Years of Trabecular Metal for Joint Replacements
FOI, Florida Hospital to Launch Clinical Study of Spinal Device
